| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 661 |
| 1 | PREDNISONE | 529 |
| 2 | DORNASE ALFA | 494 |
| 3 | TOBRAMYCIN | 426 |
| 4 | TIOTROPIUM BROMIDE | 407 |
| 5 | LUMACAFTOR AND IVACAFTOR | 397 |
| 6 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 393 |
| 7 | MONTELUKAST SODIUM | 332 |
| 8 | OMALIZUMAB | 319 |
| 9 | PANCRELIPASE | 305 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MENADIONE | 8 | 0.0576 |
| 1 | LUMACAFTOR AND IVACAFTOR | 397 | 0.0465 |
| 2 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL | 1 | 0.0357 |
| 3 | DORNASE ALFA | 494 | 0.0252 |
| 4 | CIPAGLUCOSIDASE ALFA-ATGA | 2 | 0.0220 |
| 5 | AZTREONAM | 137 | 0.0190 |
| 6 | TOBRAMYCIN | 426 | 0.0181 |
| 7 | CICLESONIDE | 243 | 0.0177 |
| 8 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 217 | 0.0172 |
| 9 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 87 | 0.0144 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1012 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 543 |
| 2 | Recombinant Human Deoxyribonuclease 1 [EPC] | 494 |
| 3 | Aminoglycoside Antibacterial [EPC] | 470 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 355 |
| 5 | Proton Pump Inhibitor [EPC] | 344 |
| 6 | Anti-IgE [EPC] | 319 |
| 7 | Provitamin D2 Compound [EPC] | 275 |
| 8 | Osmotic Laxative [EPC] | 244 |
| 9 | Pyridone [EPC] | 231 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 155 | 0.2253 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 543 | 0.0314 |
| 2 | Recombinant Human Deoxyribonuclease 1 [EPC] | 494 | 0.0252 |
| 3 | Aminoglycoside Antibacterial [EPC] | 470 | 0.0105 |
| 4 | Provitamin D2 Compound [EPC] | 275 | 0.0092 |
| 5 | Pyridone [EPC] | 231 | 0.0057 |
| 6 | Human alpha-1 Proteinase Inhibitor [EPC] | 22 | 0.0052 |
| 7 | Anti-IgE [EPC] | 319 | 0.0037 |
| 8 | Vitamin K [EPC] | 27 | 0.0031 |
| 9 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0030 |